Zusammenfassung
Noch vor wenigen Jahren schien das Ziel der klinischen Tumorimmunologie greifbar nahe: die Immundiagnose,. Immunprophylaxe und Immuntherapie maligner Erkrankungen. Der Nachweis tumorspezifischer Antigene in experimentellen Systemen (74), das Auftreten gegen sie gerichteter spezifischer körpereigener Immunabwehrreaktionen und schließlich die im Experiment erwiesene leichte Manipulierbarkeit dieser biologischen Vorgänge ließen keinen Zeifel daran aufkommen, daß die Diagnose, Prophylaxe und Therapie auf immunologischer Grundlage auch bei malignen Erkrankungen des Menschen nur eine Frage der Zeit sei. Dies um so mehr, als in den letzten Jahren bei fast allen untersuchten menschlichen Tumoren das Vorkommen von Tumorantigenen und Tumorabwehrreaktionen wahrscheinlich gemacht war (Tab. 1) (8, 9, 16, 29, 33, 35, 36, 37, 39, 40, 42, 49, 60, 61, 68, 69, 75, 86, 96, 97). Inzwischen wissen wir, daß tumorspezifische Antigene nicht immer streng tumorspezifisch sind. Man prägte daher den Ausdruck „tumorassoziierte Antigene“. Die Unterschiede zwischen Tumorzellen und Normalzellen sind häufig nur quantitativer Natur.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
ABELEV, G.I.: Alpha-fetoprotein in ontogenesis and its association with malignant tumors. In: KLEIN, G., WEINHOUSE, S., HADDOW, A. (Eds.), Advances in Cancer Research, Vol. 14, p. 295. New York-London: Academic Press 1971.
ALPERT, E., HERSHBERG, R., SCHUR, P. H., and ISSELBACHER, K.J.: Alpha-fetoprotein in human hepatoma; improved detection in serum, and quantitative studies using a new sensitive technique. Gastroenterology 61, 137 (1971).
BAGSHAWE, K.D.: Tumor-associated antigens. Brit. med. Bull. 30, 68 (1974).
BANJO, C., SHUSTER, J., and GOLD, P.: Intermolecular heterogeneity of the carcinoembryonic antigen. Cancer Res. 34, 2114 (1974).
BIVINS, B.A., BOYD, C.R., MEEKER, W.R., Jr., and GRIFFEN, W.O., Jr.: CEA levels and prognosis in colon carcinoma. J. surg. Oncol. 6, 413 (1974).
BODANSKY, O.: Reflections on biochemical aspects of human cancer. Cancer (Philad.) 33, 364 (1974).
BOUNAMEAUX, Y., and LE DAIN, M.: Carcinoembryonic antigen (CEA) assay; preliminary results of a clinical evaluation. In: Abstracts of the 11th International Cancer Congress, Florence, 20–26 Oct. 1974. Vol. 1: Conferences, Symposia, Workshops, p. 350. Milano: Casa Editrice Ambrosiana 1974.
BUBENIK, J., PERLMANN, P., HELMSTEIN, K., AND MOBERGER, G.: Immune response to urinary bladder tumours in man. Int. J. Cancer 5, 39 (1970).
BUFFE, D., RIMBAUT, C., LEMERLE, J., SCHWEISGUTH, O., BURTIN, P., et Rudant, C.: Présence d’une ferroprotéine d’origine tissulaire, l’α2 H, dans le sérum des enfants porteurs de tumeurs. Int. J. Cancer 5, 85 (1970).
BURTIN, P.: Membrane antigens of the colonic tumors. Cancer (Philad.) 34, 829 (1974).
CARNEGIE, P.R., CASPARY, E. A., and FIELD, E.J.: Isolation of an “antigen” from malignant tumours. Brit. J. Cancer 28, Suppl. I, 219 (1973).
CASPARY, E.A., AND FIELD, E.J.: Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Brit. med. J. 1971/II, 613.
COLIGAN, J.E., HENKART, P.A., TODD, C.W., and TERRY, W.D.: Heterogeneity of the carcinoembryonic antigen. Immunochemistry 10, 591 (1973).
CONCANNON, J. P., DALBOW, M. H., LIEBLER, G. A., BLAKE, K. E., WEIL, C.S., and COOPER, J.W.: The carcinoembryonic antigen assay in bronchogenic carcinoma. Cancer (Philad.) 34, 184 (1974).
COSTANZA, M.E., DAS, S., NATHANSON, L., RULE, A., and SCHWARTZ, R.S.: Carcinoembryonic antigen. Report of a screening study. Cancer (Philad.) 133, 583 (1974).
CURRIE, G.A.: Human cancer and immunology. In: Raven, R.W. (Ed.): Modern Trends in Oncology. Part 1: Research Progress, p. 127. London: Butterworth 1973.
CURRIE, G.A.: The role of circulating antigen as an inhibitor of tumour immunity in man. Brit. J. Cancer 28, Suppl. I, 153 (1973).
DHAR, P., MOORE, T., ZAMCHECK, N., AND KUPCHIK, H. Z.: Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. J. Amer. med. Ass. 221, 31 (1972).
DICKINSON, J.P., CASPARY, E.A., AND FIELD, E.J.: A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Brit. J. Cancer 27, 99 (1973).
DICKINSON, J.P., and CASPARY, E.A.: The chemical nature of cancer basic protein. Brit. J. Cancer 28, Suppl. I, 224 (1973).
DICKINSON, J.P., MCDERMOTT, J. R., SMITH, J. K., and CASPARY, E.A.: A common tumour specific antigen. H. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues. Brit. J. Cancer 29, 425 (1974).
ELGORT, D.A., ABELEV, G.I., LEVINA, D.M., MARIENBACH, E.V., MARTOCHKINA, G. A., LASKINA, A.V., and SOLOVJEVA, E.A.: Immunoradioautography test for alpha-fetoprotein in the differential diagnosis of germinogenic tumors of the testis and in the evaluation of effectiveness of their treatment. Int. J. Cancer 11, 586 (1973).
EVELEIGH, J.W.: Heterogeneity of carcinoembryonic antigen. Cancer Res. 34, 2122 (1974).
FASS, L., HERBERMAN, R. B., ZIEGLER, J. L., and KIRYABWIRE, J. W. M.: Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells. Lancet 1970/I, 116.
FIELD, E.J.: Immunological diagnosis of cancer. In: Raven, R.W. (Ed.), Modern Trends in Oncology. Part 1: Research Progress, p. 183. London: Butterworth 1973.
Field, E.J., Caspary, E.A., and Smith, K. S.: Macrophage electrophoretic mobility (MEM) test in cancer; a critical evaluation. Brit. J. Cancer 28, Suppl. I, 208 (1973).
FISHMAN, W. H.: Carcinoplacental isoenzyme antigens. In: Weber, G. (Ed.), Advances in Enzyme Regulation. Vol. 11, p. 293. Oxford-New York-Toronto-Sydney-Braunschweig: Pergamon Press 1973.
FISHMAN, W. H.: Perspectives on alkaline phosphatase isoenzymes. Amer. J. Med. 56, 617 (1974).
GOLD, P., and FREEDMAN, S.O.: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. exp. Med. 121, 439 (1965).
GOLDSTONE, A. H., KERR, L., AND IRVINE, W.J.: The macrophage electrophoretic migration test in cancer. Clin. exp. Immunol. 14, 469 (1973).
GOLTZMAN, D., POTTS, J. T., Jr., RIDGWAY, E.C., and MALOOF, F.: Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. New Engl. J. Med. 290, 1035 (1974).
HALL, T.C.: Ectopic synthesis and paraneoplastic syndromes. Cancer Res. 34, 2088 (1974).
HALTERMAN, R. H., LEVENTHAL, B.G., and MANN, D.L.: An acute-leukemia antigen; correlation with clinical status. New Engl. J. Med. 287, 1272 (1972).
HANSEN, H.J., SNYDER, J.J., MILLER, E., VANDEVOORDE, J.P., MILLER, O.N., HINES, L. R., and BURNS, J.J.: Carcinoembryonic antigen (CEA) assay; a laboratory adjunct in the diagnosis and management of cancer. Hum. Path. 5, 139 (1974).
HARRIS, R., VIZA, D., TODD, R., PHILLIPS, J., SUGAR, R., JENNISON, R. F., MARRIOTT, G., and GLEESON, M. H.: Detection of human leukaemia associated antigens in leukaemia serum and normal embryos. Nature (Lond.) 223, 556 (1971).
HELLSTRöM, I., HELLSTRöM, K.E., PIERCE, G.E., and BILL, A. H.: Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc. natl. Acad. Sci. US 60, 1231 (1968).
HELLSTRöM, I., HELLSTRöm, K.E., SJöGREN, H. O., and WARNER, G. A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1 (1971a).
HELLSTRöM, L, HELLSTRöM, K.E., SJöGREN, H. O., and WARNER, G. A.: Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity. Int. J. Cancer 8, 185 (1971b).
HELLSTRöM, K. E., AND HELLSTRöM, I.: Immunity to neuroblastomas and melanomas. Ann. Rev. Med. 23, 19 (1972).
HELLSTRöM, K.E., and HELLSTRöM, I.: Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Advanc. Immunol. 18, 209 (1974).
HENLE, G., HENLE, W., CLIFFORD, P., DIEHL, V., KAFUKO, G.W., KIRYA, B.G., KLEIN, G., MORROW, R. H., MUNUBE, G.M.R., PIKE, P., TUKEI, P.M., and ZIEGLER, J. L.: Antibodies to Epstein-Barr virus in Burkitt’ s lymphoma and control groups. J. nat. Cancer Inst. 43, 1147 (1969).
HENLE, G., and HENLE, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bact. 91, 1248 (1966).
HENLE, W., HENLE, G., GUNVéN, P., KLEIN, G., CLIFFORD, P., and SINGH, S.: Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt’ s lymphoma. Comparison of dying patients with long-term survivors. J. nat. Cancer Inst. 50, 1163 (1973).
HOLYOKE, E.D., CHU, T. M., and MURPHY, G.P.: CEA as a monitor of gastrointestinal malignancy. Cancer (Philad.) 35, 830 (1975).
HUGHES, L.E., and LYTTON, B.: Antigenic properties of human tumours: delayed cutaneous hypersensitivity reactions. Brit. med. J. 1964/I, 209.
KHOO, S. K., and MACKAY, L.R.: Carcinoembryonic antigen in serum in diseases of the liver and pancreas. J. clin. Path. 26, 470 (1973).
KHOO, S.K., and MACKAY, E.V.: Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term follow-up of female genital cancer. Cancer (Philad.) 34, 542 (1974).
KLEIN, E.: Introduction: diagnosis and immunotherapy of cancer. Nat. Cancer Inst. Monogr. 35, 331 (1972).
KLEIN, G., CLIFFORD, P., KLEIN, E., and STJERNSWäRD, J.: Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc. natl. Acad. Sci. US 55, 1628 (1966).
KLEIN, G., CLIFFORD, P., HENLE, G., HENLE, W., GEERING, G., and OLD, L. J.: EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int. J. Cancer 4, 416 (1969).
KLEIST, S. VON, CHAVANEL, G., and BURTIN, P.: Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc. natl. Acad. Sci. US 69, 2492 (1972).
KOHN, J., and WEAVER, P.C.: Serum-alpha1-fetoprotein in hepatocellular carcinoma. Lancet 1974/II, 334.
KUPCHIK, H. Z., and ZAMCHECK, N.: Carcinoembryonic antigen(s) in liver disease. II. Isolation from human cirrhotic liver and serum and from normal liver. Gastroenterology 63, 95 (1972).
LAURENCE, D.J.R., and NEVILLE, A.M.: Foetal antigens and their role in the diagnosis and clinical management of human neoplasms; a review. Brit. J. Cancer 26, 335 (1972).
LEHMANN, F.G.: Der Nachweis von α1-Fetoprotein bei internen Erkrankungen — aktueller Stand des Problems. Internist 13, 332 (1972).
LEHMANN, F.G., und LEHMANN, D.: Neue immunologische Techniken und quantitative Bestimmung von α1-Fetoproteinen in der Tumordiagnostik. Verh. dtsch. Ges. inn. Med. 78, 841 (1972).
LEHMANN, F.G., und LEHMANN, D.: Vergleich verschiedener Methoden zum serologischen Nachweis von α1-Fetoprotein im Serum. Z. klin. Chem. 11, 339 (1973).
LEHMANN, F.G.: Tumorantigene. Dtsch. med. Wschr. 99, 410 (1974).
LEHMANN, F.G., und LEHMANN, D.: Alpha1-Fetoprotein in malignen Tumoren. Klin. Wschr. 52, 222 (1974).
LEVI, M. M., KELLER, S., and MANDL, I.: Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions. Amer. J. Obstet. Gynec. 105, 856 (1969).
LEWIS, M.G., IKONOPISOV, R.L., NAIRN, R.C., PHILLIPS, T. M., FAIRLEY, G. H., BODENHAM, D.C., and ALEXANDER, P.: Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Brit. med. J. 1969/III, 547.
LO GERFO, P., LO GERFO, F., HERTER, F., BARKER, H. G., and HANSEN, H. J.: Tumor-associated antigen in patients with carcinoma of the colon. Amer. J. Surg. 123, 127 (1972).
MACH, J.P., and Pusztaszeri, G.: Carcinoembryonic antigen (CEA); demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry 9, 1031 (1972).
MACH, J.P., JAEGER, P., BERTHOLET, M.M., RUEGSEGGER, C.H., LOOSLI, R. M., and PETTAVEL, J.: Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet 1974/II, 535.
MACKAY, A.M., PATEL, S., CARTER, S., STEVENS, U., LAURENCE, D.J.R., COOPER, E.H., and NEVILLE, A.M.: Role of serial plasma CEA assays in detection of recurrent and metastatic colorectal carcinomas. Brit. med. J. 1974/IV, 382.
MCPHERSON, T.A., BAND, P.R., GRACE, M., HYDE, H.A., and PATWARDHAN, V.C.: Carcinoembryonic antigen (CEA): comparison of the Farr and solid-phase methods for detection of CEA. Int. J. Cancer 12, 42 (1973).
MILLER, A.B.: The joint National Cancer Institute of Canada/American Cancer Society study of a test for carcinoembryonic antigen (CEA). Cancer (Philad.) 34, 932 (1974).
MORTON, D. L., MALMGREN, R.A., HOLMES, E.C., and KETCHAM, A. S.: Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233 (1968).
MORTON, D. L., MALMGREN, R. A., HALL, W. T., and SCHIDLOVSKY, G.: Immunologic and virus studies with human sarcomas. Surgery 66, 152 (1969).
Neville, A.M., Nery, R., Hall, R. R., Turberville, C., and Laurence, D.J.R.: Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma. Brit. J. Cancer 28, Suppl. I, 198 (1973).
NEVILLE, A.M., and LAURENCE, D.J.R.: Report of the workshop on the carcinoembryonic antigen (CEA): the present position and proposals for future investigation. Int. J. Cancer 14, 1 (1974).
NEVILLE, A. M: Clinical value of tumour-associated antigens. J. clin. Path. 27, Suppl. (Roy. Coll. Path.), 7, 119 (1974).
O’CONOR, G.T., TATARINOV, YU. S., ABELEV, G.I., and URIEL, J.: A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer (Philad.) 25, 1091 (1970).
OLD, L. J., and BOYSE, E.A.: Immunology of experimental tumors. Ann. Rev. Med. 15, 167 (1964).
ORDER, S.E., PORTER, M., and HELLMAN, S.: Hodgkin’s disease: evidence for a tumor-associated antigen. New Engl. J. Med. 285, 471 (1971).
PHILLIPS, R. W., and MANILDI, E. R.: Abnormal serum isoenzyme of leucine aminopeptidase (LAP) in malignant neoplastic disease. Cancer (Philad.) 34, 350 (1974).
PLETSCH, Q., and Goldenberg, D.M.: Molecular size of carcino-embryonic antigen in the plasma of patients with malignant disease. J. nat. Cancer Inst. 53, 1201 (1974).
PRITCHARD, J.A.V., MOORE, J. L., SUTHERLAND, W. H., and JOSLIN, C.A.F.: Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Brit. J. Cancer 28, Suppl. I, 229 (1973).
PUSZTASZERI, G., and MACH, J. P.: Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry 10, 197 (1973).
ROSEN, S.W., WEINTRAUB, B.D., VAITUKAITIS, J. L., SUSSMAN, H.H., HERSHMAN, J. M., and MUGGIA, F.M.: Placental proteins and their subunits as tumor markers. Ann. intern. Med. 82, 71 (1975).
Ruoslahti, E., Salaspuro, M., Pihko, H., Andersson, L., and Seppälä, M.: Serum α-fetoprotein: diagnostic significance in liver disease. Brit. med. J. 1974/II, 527.
SCHAPIRA, F., HATZFELD, A., and WEBER, A.: Fetal type of isoenzymes in cancer. In: Abstracts of the 11th International Cancer Congress, Florence, 20–26 Oct. 1974. Vol. 1: Conferences, Symposia, Workshops, p. 123. Milano: Casa Editrice Ambrosiana 1974.
SHUSTER, J., LIVINGSTONE, A., BANJO, C., SILVER, H. K. B., FREEDMAN, S.O., and GOLD, P.: Immunologic diagnosis of human cancers. Amer. J. clin. Path. 62, 243 (1974).
SILVER, H.K.B., GOLD, P., SHUSTER, S., JAVITT, N.B., FREEDMAN, S.O., and FINLAYSON, N.D.C.: Alpha1-fetoprotein in chronic liver disease. New Engl. J. Med. 291., 506 (1974).
SKARIN, A. T., DELWICHE, R., ZAMCHECK, N., LOKICH, J.J., and FREI, E. III: Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (Philad.) 33, 1239 (1974).
SMITH, R. T., KLEIN, G., KLEIN, E., and CLIFFORD, P.: Studies of the membrane phenomenon in cultured and biopsy cell lines from the Burkitt lymphoma. In: DAUSSET, J., HAMBURGER, J., MATHE, G. (Eds.), Advance in transplantation. Proceedings of the 1st international congress of the Transplantation Society, Paris, June 27–30, 1967, p. 483. Baltimore: Williams & Wilkins 1968.
STEWARD, A.M., NIXON, D., ZAMCHECK, N., and AISENBERG, A.: Carcinoembryonic antigen in breast cancer patients; serum levels and disease progress. Cancer (Philad.) 33, 1246 (1974).
STEWART, T. H. M.: The immunological reactivity of patients with cancer; a preliminary report. Canad. med. Ass. J. 99, 342 (1968).
TAL, C., RAYCHAUDHURI, A., MEGEL, H., HERBERMAN, R. B., and BUNCHER, C.R.: Simplified technique for the T-globulin cancer test. J. nat. Cancer Inst. 51, 33 (1973).
TATARINOV, YU. S.: Presence of embryospecific alpha globulin in the serum of patients with primary hepatocellular carcinoma. Vop. med. Khim. 10, 90 (1964).
TODD, C.W.: Carcinoembryonic antigen. In: Abstracts of the 11th International Cancer Congress, Florence 20–26 Oct., 1974. Vol. 1: Conferences, Symposia, Workshops, p. 32. Milano: Casa Editrice Ambrosiana 1974.
TSOU, K.C., MCCOY, M.G., and LO, K.W.: An isoenzyme of 5′-nucleotide phosphodiesterase and α-fetoprotein in human hepatic cancer patient sera. Cancer Res. 34, 2459 (1974).
VINCENT, R.G., and CHU, T.M.: Carcinoembryonic antigen in patients with carcinoma of the lung. J. thorac. cardiovasc. Surg. 66, 320 (1973).
VOGEL, C.L., PRIMACK, A., MCINTIRE, K.R., CARBONE, P.P., and ANTHONY, P.P.: Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations. Cancer (Philad.) 33, 959 (1974).
WEINTRAUB, B.D., and ROSEN, S.W.: Competitive radioassays and “specific” tumor markers. Metabolism 22, 1119 (1973).
WOOD, W. C., and MORTON, D. L.: Host immune response to a common cell-surface antigen in human sarcomas. Detection by cytotoxicity tests. New Engl. J. Med. 284, 569 (1971).
YACHI, A., MATSUURA, Y., CARPENTER, C.M., and HYDE, L.: Immunochemical studies on human lung cancer antigens soluble in 50% saturated ammonium sulfate. J. nat. Cancer Inst. 40, 663 (1968).
ZAMCHECK, N.: Carcinoembryonic antigen; quantitative variations in circulating levels in benign and malignant digestive tract diseases. Advanc. intern. Med. 19, 413 (1974).
ZAMCHECK, N., and KUPCHIK, H. Z.: The interdependence of clinical investigations and methodological development in the early evolution of assays for carcinoembryonic antigen. Cancer Res. 34, 2131 (1974).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Gallmeier, W.M., Bruntsch, U. (1975). Immunologische Bestimmung von Tumorantigenen. In: Lang, H., Rick, W., Róka, L. (eds) Anwendung immunologischer Methoden. Zusammenarbeit von Klinik und Klinischer Chemie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80984-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-80984-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07481-6
Online ISBN: 978-3-642-80984-2
eBook Packages: Springer Book Archive